Global Dry Age-Related Macular Degeneration Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 246416
  • calendar_today Published On: Dec, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Dry Age-Related Macular Degeneration market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Dry Age-Related Macular Degeneration size is estimated to be USD million in 2026 from USD million in 2020, with a change % between 2020 and 2021. The global Dry Age-Related Macular Degeneration market size is expected to grow at a CAGR of % for the next five years.

Market segmentation

Dry Age-Related Macular Degeneration market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Oral

Injectables

Market segment by Application, can be divided into

Above 40 Years

Above 60 Years

Above 75 Years

Market segment by players, this report covers

Santen Pharmaceuticals

Allergan

Bausch Health

Alimera Science

Phio Pharmaceuticals

Ocumension Therapeutics

Belite Bio

Kubota Vision

Iveric Bio

Eyestem Research

Y2 Solution

Stealth Biotherapeutics

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Dry Age-Related Macular Degeneration product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Dry Age-Related Macular Degeneration, with revenue, gross margin and global market share of Dry Age-Related Macular Degeneration from 2019 to 2021.

Chapter 3, the Dry Age-Related Macular Degeneration competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Dry Age-Related Macular Degeneration market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe Dry Age-Related Macular Degeneration research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Dry Age-Related Macular Degeneration

1.2 Classification of Dry Age-Related Macular Degeneration by Type

1.2.1 Overview: Global Dry Age-Related Macular Degeneration Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Dry Age-Related Macular Degeneration Revenue Market Share by Type in 2020

1.2.3 Oral

1.2.4 Injectables

1.3 Global Dry Age-Related Macular Degeneration Market by Application

1.3.1 Overview: Global Dry Age-Related Macular Degeneration Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Above 40 Years

1.3.3 Above 60 Years

1.3.4 Above 75 Years

1.4 Global Dry Age-Related Macular Degeneration Market Size & Forecast

1.5 Global Dry Age-Related Macular Degeneration Market Size and Forecast by Region

1.5.1 Global Dry Age-Related Macular Degeneration Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Dry Age-Related Macular Degeneration Market Size by Region, (2016-2021)

1.5.3 North America Dry Age-Related Macular Degeneration Market Size and Prospect (2016-2026)

1.5.4 Europe Dry Age-Related Macular Degeneration Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Dry Age-Related Macular Degeneration Market Size and Prospect (2016-2026)

1.5.6 South America Dry Age-Related Macular Degeneration Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Dry Age-Related Macular Degeneration Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Dry Age-Related Macular Degeneration Market Drivers

1.6.2 Dry Age-Related Macular Degeneration Market Restraints

1.6.3 Dry Age-Related Macular Degeneration Trends Analysis

2 Company Profiles

2.1 Santen Pharmaceuticals

2.1.1 Santen Pharmaceuticals Details

2.1.2 Santen Pharmaceuticals Major Business

2.1.3 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product and Solutions

2.1.4 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Santen Pharmaceuticals Recent Developments and Future Plans

2.2 Allergan

2.2.1 Allergan Details

2.2.2 Allergan Major Business

2.2.3 Allergan Dry Age-Related Macular Degeneration Product and Solutions

2.2.4 Allergan Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Allergan Recent Developments and Future Plans

2.3 Bausch Health

2.3.1 Bausch Health Details

2.3.2 Bausch Health Major Business

2.3.3 Bausch Health Dry Age-Related Macular Degeneration Product and Solutions

2.3.4 Bausch Health Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Bausch Health Recent Developments and Future Plans

2.4 Alimera Science

2.4.1 Alimera Science Details

2.4.2 Alimera Science Major Business

2.4.3 Alimera Science Dry Age-Related Macular Degeneration Product and Solutions

2.4.4 Alimera Science Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Alimera Science Recent Developments and Future Plans

2.5 Phio Pharmaceuticals

2.5.1 Phio Pharmaceuticals Details

2.5.2 Phio Pharmaceuticals Major Business

2.5.3 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product and Solutions

2.5.4 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Phio Pharmaceuticals Recent Developments and Future Plans

2.6 Ocumension Therapeutics

2.6.1 Ocumension Therapeutics Details

2.6.2 Ocumension Therapeutics Major Business

2.6.3 Ocumension Therapeutics Dry Age-Related Macular Degeneration Product and Solutions

2.6.4 Ocumension Therapeutics Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Ocumension Therapeutics Recent Developments and Future Plans

2.7 Belite Bio

2.7.1 Belite Bio Details

2.7.2 Belite Bio Major Business

2.7.3 Belite Bio Dry Age-Related Macular Degeneration Product and Solutions

2.7.4 Belite Bio Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Belite Bio Recent Developments and Future Plans

2.8 Kubota Vision

2.8.1 Kubota Vision Details

2.8.2 Kubota Vision Major Business

2.8.3 Kubota Vision Dry Age-Related Macular Degeneration Product and Solutions

2.8.4 Kubota Vision Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Kubota Vision Recent Developments and Future Plans

2.9 Iveric Bio

2.9.1 Iveric Bio Details

2.9.2 Iveric Bio Major Business

2.9.3 Iveric Bio Dry Age-Related Macular Degeneration Product and Solutions

2.9.4 Iveric Bio Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Iveric Bio Recent Developments and Future Plans

2.10 Eyestem Research

2.10.1 Eyestem Research Details

2.10.2 Eyestem Research Major Business

2.10.3 Eyestem Research Dry Age-Related Macular Degeneration Product and Solutions

2.10.4 Eyestem Research Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Eyestem Research Recent Developments and Future Plans

2.11 Y2 Solution

2.11.1 Y2 Solution Details

2.11.2 Y2 Solution Major Business

2.11.3 Y2 Solution Dry Age-Related Macular Degeneration Product and Solutions

2.11.4 Y2 Solution Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Y2 Solution Recent Developments and Future Plans

2.12 Stealth Biotherapeutics

2.12.1 Stealth Biotherapeutics Details

2.12.2 Stealth Biotherapeutics Major Business

2.12.3 Stealth Biotherapeutics Dry Age-Related Macular Degeneration Product and Solutions

2.12.4 Stealth Biotherapeutics Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Stealth Biotherapeutics Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Dry Age-Related Macular Degeneration Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Dry Age-Related Macular Degeneration Players Market Share

3.2.2 Top 10 Dry Age-Related Macular Degeneration Players Market Share

3.2.3 Market Competition Trend

3.3 Dry Age-Related Macular Degeneration Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Dry Age-Related Macular Degeneration Revenue and Market Share by Type (2016-2021)

4.2 Global Dry Age-Related Macular Degeneration Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Dry Age-Related Macular Degeneration Revenue Market Share by Application (2016-2021)

5.2 Dry Age-Related Macular Degeneration Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Dry Age-Related Macular Degeneration Revenue by Type (2016-2026)

6.2 North America Dry Age-Related Macular Degeneration Revenue by Application (2016-2026)

6.3 North America Dry Age-Related Macular Degeneration Market Size by Country

6.3.1 North America Dry Age-Related Macular Degeneration Revenue by Country (2016-2026)

6.3.2 United States Dry Age-Related Macular Degeneration Market Size and Forecast (2016-2026)

6.3.3 Canada Dry Age-Related Macular Degeneration Market Size and Forecast (2016-2026)

6.3.4 Mexico Dry Age-Related Macular Degeneration Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Dry Age-Related Macular Degeneration Revenue by Type (2016-2026)

7.2 Europe Dry Age-Related Macular Degeneration Revenue by Application (2016-2026)

7.3 Europe Dry Age-Related Macular Degeneration Market Size by Country

7.3.1 Europe Dry Age-Related Macular Degeneration Revenue by Country (2016-2026)

7.3.2 Germany Dry Age-Related Macular Degeneration Market Size and Forecast (2016-2026)

7.3.3 France Dry Age-Related Macular Degeneration Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Dry Age-Related Macular Degeneration Market Size and Forecast (2016-2026)

7.3.5 Russia Dry Age-Related Macular Degeneration Market Size and Forecast (2016-2026)

7.3.6 Italy Dry Age-Related Macular Degeneration Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Dry Age-Related Macular Degeneration Revenue by Type (2016-2026)

8.2 Asia-Pacific Dry Age-Related Macular Degeneration Revenue by Application (2016-2026)

8.3 Asia-Pacific Dry Age-Related Macular Degeneration Market Size by Region

8.3.1 Asia-Pacific Dry Age-Related Macular Degeneration Revenue by Region (2016-2026)

8.3.2 China Dry Age-Related Macular Degeneration Market Size and Forecast (2016-2026)

8.3.3 Japan Dry Age-Related Macular Degeneration Market Size and Forecast (2016-2026)

8.3.4 South Korea Dry Age-Related Macular Degeneration Market Size and Forecast (2016-2026)

8.3.5 India Dry Age-Related Macular Degeneration Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Dry Age-Related Macular Degeneration Market Size and Forecast (2016-2026)

8.3.7 Australia Dry Age-Related Macular Degeneration Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Dry Age-Related Macular Degeneration Revenue by Type (2016-2026)

9.2 South America Dry Age-Related Macular Degeneration Revenue by Application (2016-2026)

9.3 South America Dry Age-Related Macular Degeneration Market Size by Country

9.3.1 South America Dry Age-Related Macular Degeneration Revenue by Country (2016-2026)

9.3.2 Brazil Dry Age-Related Macular Degeneration Market Size and Forecast (2016-2026)

9.3.3 Argentina Dry Age-Related Macular Degeneration Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Dry Age-Related Macular Degeneration Revenue by Type (2016-2026)

10.2 Middle East & Africa Dry Age-Related Macular Degeneration Revenue by Application (2016-2026)

10.3 Middle East & Africa Dry Age-Related Macular Degeneration Market Size by Country

10.3.1 Middle East & Africa Dry Age-Related Macular Degeneration Revenue by Country (2016-2026)

10.3.2 Turkey Dry Age-Related Macular Degeneration Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Dry Age-Related Macular Degeneration Market Size and Forecast (2016-2026)

10.3.4 UAE Dry Age-Related Macular Degeneration Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Dry Age-Related Macular Degeneration Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Dry Age-Related Macular Degeneration Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Dry Age-Related Macular Degeneration Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Dry Age-Related Macular Degeneration Revenue (USD Million) by Region (2016-2021)

Table 5. Global Dry Age-Related Macular Degeneration Revenue Market Share by Region (2021-2026)

Table 6. Santen Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 7. Santen Pharmaceuticals Major Business

Table 8. Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product and Solutions

Table 9. Santen Pharmaceuticals Dry Age-Related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Allergan Corporate Information, Head Office, and Major Competitors

Table 11. Allergan Major Business

Table 12. Allergan Dry Age-Related Macular Degeneration Product and Solutions

Table 13. Allergan Dry Age-Related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Bausch Health Corporate Information, Head Office, and Major Competitors

Table 15. Bausch Health Major Business

Table 16. Bausch Health Dry Age-Related Macular Degeneration Product and Solutions

Table 17. Bausch Health Dry Age-Related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Alimera Science Corporate Information, Head Office, and Major Competitors

Table 19. Alimera Science Major Business

Table 20. Alimera Science Dry Age-Related Macular Degeneration Product and Solutions

Table 21. Alimera Science Dry Age-Related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Phio Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 23. Phio Pharmaceuticals Major Business

Table 24. Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product and Solutions

Table 25. Phio Pharmaceuticals Dry Age-Related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Ocumension Therapeutics Corporate Information, Head Office, and Major Competitors

Table 27. Ocumension Therapeutics Major Business

Table 28. Ocumension Therapeutics Dry Age-Related Macular Degeneration Product and Solutions

Table 29. Ocumension Therapeutics Dry Age-Related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Belite Bio Corporate Information, Head Office, and Major Competitors

Table 31. Belite Bio Major Business

Table 32. Belite Bio Dry Age-Related Macular Degeneration Product and Solutions

Table 33. Belite Bio Dry Age-Related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Kubota Vision Corporate Information, Head Office, and Major Competitors

Table 35. Kubota Vision Major Business

Table 36. Kubota Vision Dry Age-Related Macular Degeneration Product and Solutions

Table 37. Kubota Vision Dry Age-Related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Iveric Bio Corporate Information, Head Office, and Major Competitors

Table 39. Iveric Bio Major Business

Table 40. Iveric Bio Dry Age-Related Macular Degeneration Product and Solutions

Table 41. Iveric Bio Dry Age-Related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Eyestem Research Corporate Information, Head Office, and Major Competitors

Table 43. Eyestem Research Major Business

Table 44. Eyestem Research Dry Age-Related Macular Degeneration Product and Solutions

Table 45. Eyestem Research Dry Age-Related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Y2 Solution Corporate Information, Head Office, and Major Competitors

Table 47. Y2 Solution Major Business

Table 48. Y2 Solution Dry Age-Related Macular Degeneration Product and Solutions

Table 49. Y2 Solution Dry Age-Related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Stealth Biotherapeutics Corporate Information, Head Office, and Major Competitors

Table 51. Stealth Biotherapeutics Major Business

Table 52. Stealth Biotherapeutics Dry Age-Related Macular Degeneration Product and Solutions

Table 53. Stealth Biotherapeutics Dry Age-Related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Global Dry Age-Related Macular Degeneration Revenue (USD Million) by Players (2019-2021)

Table 55. Global Dry Age-Related Macular Degeneration Revenue Share by Players (2019-2021)

Table 56. Breakdown of Dry Age-Related Macular Degeneration by Company Type (Tier 1, Tier 2 and Tier 3)

Table 57. Dry Age-Related Macular Degeneration Players Head Office, Products and Services Provided

Table 58. Dry Age-Related Macular Degeneration Mergers & Acquisitions in the Past Five Years

Table 59. Dry Age-Related Macular Degeneration New Entrants and Expansion Plans

Table 60. Global Dry Age-Related Macular Degeneration Revenue (USD Million) by Type (2016-2021)

Table 61. Global Dry Age-Related Macular Degeneration Revenue Share by Type (2016-2021)

Table 62. Global Dry Age-Related Macular Degeneration Revenue Forecast by Type (2021-2026)

Table 63. Global Dry Age-Related Macular Degeneration Revenue by Application (2016-2021)

Table 64. Global Dry Age-Related Macular Degeneration Revenue Forecast by Application (2021-2026)

Table 65. North America Dry Age-Related Macular Degeneration Revenue by Type (2016-2021) & (USD Million)

Table 66. North America Dry Age-Related Macular Degeneration Revenue by Type (2021-2026) & (USD Million)

Table 67. North America Dry Age-Related Macular Degeneration Revenue by Application (2016-2021) & (USD Million)

Table 68. North America Dry Age-Related Macular Degeneration Revenue by Application (2021-2026) & (USD Million)

Table 69. North America Dry Age-Related Macular Degeneration Revenue by Country (2016-2021) & (USD Million)

Table 70. North America Dry Age-Related Macular Degeneration Revenue by Country (2021-2026) & (USD Million)

Table 71. Europe Dry Age-Related Macular Degeneration Revenue by Type (2016-2021) & (USD Million)

Table 72. Europe Dry Age-Related Macular Degeneration Revenue by Type (2021-2026) & (USD Million)

Table 73. Europe Dry Age-Related Macular Degeneration Revenue by Application (2016-2021) & (USD Million)

Table 74. Europe Dry Age-Related Macular Degeneration Revenue by Application (2021-2026) & (USD Million)

Table 75. Europe Dry Age-Related Macular Degeneration Revenue by Country (2016-2021) & (USD Million)

Table 76. Europe Dry Age-Related Macular Degeneration Revenue by Country (2021-2026) & (USD Million)

Table 77. Asia-Pacific Dry Age-Related Macular Degeneration Revenue by Type (2016-2021) & (USD Million)

Table 78. Asia-Pacific Dry Age-Related Macular Degeneration Revenue by Type (2021-2026) & (USD Million)

Table 79. Asia-Pacific Dry Age-Related Macular Degeneration Revenue by Application (2016-2021) & (USD Million)

Table 80. Asia-Pacific Dry Age-Related Macular Degeneration Revenue by Application (2021-2026) & (USD Million)

Table 81. Asia-Pacific Dry Age-Related Macular Degeneration Revenue by Region (2016-2021) & (USD Million)

Table 82. Asia-Pacific Dry Age-Related Macular Degeneration Revenue by Region (2021-2026) & (USD Million)

Table 83. South America Dry Age-Related Macular Degeneration Revenue by Type (2016-2021) & (USD Million)

Table 84. South America Dry Age-Related Macular Degeneration Revenue by Type (2021-2026) & (USD Million)

Table 85. South America Dry Age-Related Macular Degeneration Revenue by Application (2016-2021) & (USD Million)

Table 86. South America Dry Age-Related Macular Degeneration Revenue by Application (2021-2026) & (USD Million)

Table 87. South America Dry Age-Related Macular Degeneration Revenue by Country (2016-2021) & (USD Million)

Table 88. South America Dry Age-Related Macular Degeneration Revenue by Country (2021-2026) & (USD Million)

Table 89. Middle East & Africa Dry Age-Related Macular Degeneration Revenue by Type (2016-2021) & (USD Million)

Table 90. Middle East & Africa Dry Age-Related Macular Degeneration Revenue by Type (2021-2026) & (USD Million)

Table 91. Middle East & Africa Dry Age-Related Macular Degeneration Revenue by Application (2016-2021) & (USD Million)

Table 92. Middle East & Africa Dry Age-Related Macular Degeneration Revenue by Application (2021-2026) & (USD Million)

Table 93. Middle East & Africa Dry Age-Related Macular Degeneration Revenue by Country (2016-2021) & (USD Million)

Table 94. Middle East & Africa Dry Age-Related Macular Degeneration Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Dry Age-Related Macular Degeneration Picture

Figure 2. Global Dry Age-Related Macular Degeneration Revenue Market Share by Type in 2020

Figure 3. Oral

Figure 4. Injectables

Figure 5. Dry Age-Related Macular Degeneration Revenue Market Share by Application in 2020

Figure 6. Above 40 Years Picture

Figure 7. Above 60 Years Picture

Figure 8. Above 75 Years Picture

Figure 9. Global Dry Age-Related Macular Degeneration Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 10. Global Dry Age-Related Macular Degeneration Revenue and Forecast (2016-2026) & (USD Million)

Figure 11. Global Dry Age-Related Macular Degeneration Revenue Market Share by Region (2016-2026)

Figure 12. Global Dry Age-Related Macular Degeneration Revenue Market Share by Region in 2020

Figure 13. North America Dry Age-Related Macular Degeneration Revenue (USD Million) and Growth Rate (2016-2026)

Figure 14. Europe Dry Age-Related Macular Degeneration Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Asia-Pacific Dry Age-Related Macular Degeneration Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. South America Dry Age-Related Macular Degeneration Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Middle East and Africa Dry Age-Related Macular Degeneration Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Dry Age-Related Macular Degeneration Market Drivers

Figure 19. Dry Age-Related Macular Degeneration Market Restraints

Figure 20. Dry Age-Related Macular Degeneration Market Trends

Figure 21. Santen Pharmaceuticals Recent Developments and Future Plans

Figure 22. Allergan Recent Developments and Future Plans

Figure 23. Bausch Health Recent Developments and Future Plans

Figure 24. Alimera Science Recent Developments and Future Plans

Figure 25. Phio Pharmaceuticals Recent Developments and Future Plans

Figure 26. Ocumension Therapeutics Recent Developments and Future Plans

Figure 27. Belite Bio Recent Developments and Future Plans

Figure 28. Kubota Vision Recent Developments and Future Plans

Figure 29. Iveric Bio Recent Developments and Future Plans

Figure 30. Eyestem Research Recent Developments and Future Plans

Figure 31. Y2 Solution Recent Developments and Future Plans

Figure 32. Stealth Biotherapeutics Recent Developments and Future Plans

Figure 33. Global Dry Age-Related Macular Degeneration Revenue Share by Players in 2020

Figure 34. Dry Age-Related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 35. Global Top 3 Players Dry Age-Related Macular Degeneration Revenue Market Share in 2020

Figure 36. Global Top 10 Players Dry Age-Related Macular Degeneration Revenue Market Share in 2020

Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 38. Global Dry Age-Related Macular Degeneration Revenue Share by Type in 2020

Figure 39. Global Dry Age-Related Macular Degeneration Market Share Forecast by Type (2021-2026)

Figure 40. Global Dry Age-Related Macular Degeneration Revenue Share by Application in 2020

Figure 41. Global Dry Age-Related Macular Degeneration Market Share Forecast by Application (2021-2026)

Figure 42. North America Dry Age-Related Macular Degeneration Sales Market Share by Type (2016-2026)

Figure 43. North America Dry Age-Related Macular Degeneration Sales Market Share by Application (2016-2026)

Figure 44. North America Dry Age-Related Macular Degeneration Revenue Market Share by Country (2016-2026)

Figure 45. United States Dry Age-Related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 46. Canada Dry Age-Related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 47. Mexico Dry Age-Related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. Europe Dry Age-Related Macular Degeneration Sales Market Share by Type (2016-2026)

Figure 49. Europe Dry Age-Related Macular Degeneration Sales Market Share by Application (2016-2026)

Figure 50. Europe Dry Age-Related Macular Degeneration Revenue Market Share by Country (2016-2026)

Figure 51. Germany Dry Age-Related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. France Dry Age-Related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. United Kingdom Dry Age-Related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Russia Dry Age-Related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Italy Dry Age-Related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Asia-Pacific Dry Age-Related Macular Degeneration Sales Market Share by Type (2016-2026)

Figure 57. Asia-Pacific Dry Age-Related Macular Degeneration Sales Market Share by Application (2016-2026)

Figure 58. Asia-Pacific Dry Age-Related Macular Degeneration Revenue Market Share by Region (2016-2026)

Figure 59. China Dry Age-Related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Japan Dry Age-Related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. South Korea Dry Age-Related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. India Dry Age-Related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Southeast Asia Dry Age-Related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Australia Dry Age-Related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. South America Dry Age-Related Macular Degeneration Sales Market Share by Type (2016-2026)

Figure 66. South America Dry Age-Related Macular Degeneration Sales Market Share by Application (2016-2026)

Figure 67. South America Dry Age-Related Macular Degeneration Revenue Market Share by Country (2016-2026)

Figure 68. Brazil Dry Age-Related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Argentina Dry Age-Related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Middle East and Africa Dry Age-Related Macular Degeneration Sales Market Share by Type (2016-2026)

Figure 71. Middle East and Africa Dry Age-Related Macular Degeneration Sales Market Share by Application (2016-2026)

Figure 72. Middle East and Africa Dry Age-Related Macular Degeneration Revenue Market Share by Country (2016-2026)

Figure 73. Turkey Dry Age-Related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Saudi Arabia Dry Age-Related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. UAE Dry Age-Related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Methodology

Figure 77. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz